Genevac has rolled out its latest fully automated evaporator the Rocket 4D, for automatic drying or concentration of large volumes in one operation. Using the new system, which does not require any user interaction, an operator can just ...
OpGen, a provider of genomic and DNA analysis systems and services, has collaborated with Applied Maths to offer bioinformatics analysis software for microbial genomics and molecular strain typing. Under the agreement, a whole genome ...
Valeritas, insulin delivery devices maker, has announced that it has closed a structured debt financing with Capital Royalty which will provide the company with about $100m in order to further commercialize V-Go. Designed to be easier to ...
DiFusion, a US-based medical device firm focused on surgical site infections in orthopedic and spine surgery, has completed a series of in vitro tests and an in vivo study at Clemson University to validate the efficacy of its new ...
Proton therapy systems developer Mevion Medical has delivered the superconducting synchrocyclotron accelerator for its Mevion S250, which is presently under installation at the Peggy and Charles Stephenson Cancer Center at the University of ...
DKSH Business Unit Healthcare has opened its new healthcare distribution center in Seoul, South Korea. Located close to key hospitals in Seoul, the distribution center will manage the emergency deliveries of mainly medical devices. The ...
Tags: Health, Medicine, medical devices
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Celgene International's oral anti-cancer therapy Pomalidomide. The positive results from the MM-003 study of ...
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's Tafinlar (dabrafenib) and Mekinist (trametinib) as single-agent therapies for unresectable or metastatic melanoma with BRAF V600E mutation. Tafinlar is not indicated ...
Danish biotechnology company Zealand Pharma and partner, the Swiss pharma group Helsinn have jointly cHelsinn's Phase IIa study with elsiglutide for the prevention of chemotherapy-induced diarrhea in cancer patients has been completed with ...
Tags: Health, Medicine, biotechnology
India-based drugmaker Sun Pharmaceutical Industries is said to be in advanced negotiations to acquire Sweden-based Meda in a deal valued at $5-$6bn. Sources close to the deal were quoted by Reuters as saying that the acquisition will ...
CryoXtract Instruments, a developer of automation solutions for preserving and optimizing frozen biological samples, has obtained US patent covering systems, methods and devices for its frozen sample aliquotting technology. Harvard ...
US-based specialty pharmaceutical company, pSivida has entered into a funded technology evaluation agreement with an undisclosed pharmaceutical company. The deal will assess the Durasert technology, pSivida's core technology system, for ...
Daiichi Sankyo Company has filed a supplemental new drug application for extended indication of anticancer agent Topotecin intravenous drip infusion 40mg, 100mg with the Japan's Ministry of Health, Labor and Welfare. Topotecin intravenous ...
MannKind has completed the Phase 3 clinical study of Afrezza (insulin human [rDNA origin]) in patients with type 1 diabetes and expects to release the data in the summer of 2013. Administered using MannKind's next-generation inhaler, the ...
Speciality pharmaceutical and diagnostic company, Prometheus is set to begin Proclivity02, a study that compares the sequence of Proleukin (High Dose Interleukin-2 (HD IL-2) therapy at multi centers in US for metastatic melanoma (mM). ...